cholangiocarcinoma
Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
Effects of the anti-<span class="gene" id="17341899-0-20-52">epidermal growth factor receptor</span> antibody cetuximab on <span class="disease" id="17341899-0-75-93">cholangiocarcinoma</span> of the liver.